ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,638.94
      2.13%
      US Tech 100
      19,151.20
      2.23%
      Dow Jones
      41,488.19
      1.65%
      Brent Oil
      70.28
      0.51%
      Bitcoin
      83,864.36
      3.49%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Acticor Biotech (ALACT) Quote

      Acticor Biotech

      Acticor Biotech (ALACT)

      EU
      0.25
      0.00
      (0.00%)
      Closed March 14 12:30PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.25
      Bid
      0.001
      Ask
      0.001
      Volume
      0.00
      0.00 Day's Range 0.00
      0.22 52 Week Range 4.50
      Market Cap
      3.939M
      Previous Close
      0.25
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      0.00
      Shares Outstanding
      15,755,227
      Dividend Yield
      -
      PE Ratio
      -0.21
      Earnings Per Share (EPS)
      -1.18
      Revenue
      2.63M
      Net Profit
      -18.64M

      About Acticor Biotech

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.acticor-biotech.com
      Headquarters
      Paris, Paris, Fra
      Founded
      -
      Acticor Biotech is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALACT. The last closing price for Acticor Biotech was 0.25 €. Over the last year, Acticor Biotech shares have traded in a share price range of 0.22 € to 4.50 €.

      Acticor Biotech currently has 15,755,227 shares outstanding. The market capitalization of Acticor Biotech is 3.94 € million. Acticor Biotech has a price to earnings ratio (PE ratio) of -0.21.

      Ask ADVFN Intelligence (AI)

      ALACT Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.250.250.2500DE
      4000.250.250.2500DE
      12000.250.250.2500DE
      26-0.22-46.80851063830.470.890.22295090.53275964DE
      52-4.25-94.44444444444.54.50.22498840.79721239DE
      156-7.651-96.83584356417.901110.22189391.43554866DE
      2600.09864.47368421050.152110.142589731.26882854DE

      ALACT - Frequently Asked Questions (FAQ)

      What is the current Acticor Biotech share price?
      The current share price of Acticor Biotech is 0.25 €
      How many Acticor Biotech shares are in issue?
      Acticor Biotech has 15,755,227 shares in issue
      What is the market cap of Acticor Biotech?
      The market capitalisation of Acticor Biotech is EUR 3.94M
      What is the 1 year trading range for Acticor Biotech share price?
      Acticor Biotech has traded in the range of 0.22 € to 4.50 € during the past year
      What is the PE ratio of Acticor Biotech?
      The price to earnings ratio of Acticor Biotech is -0.21
      What is the cash to sales ratio of Acticor Biotech?
      The cash to sales ratio of Acticor Biotech is 1.5
      What is the reporting currency for Acticor Biotech?
      Acticor Biotech reports financial results in EUR
      What is the latest annual turnover for Acticor Biotech?
      The latest annual turnover of Acticor Biotech is EUR 2.63M
      What is the latest annual profit for Acticor Biotech?
      The latest annual profit of Acticor Biotech is EUR -18.64M
      What is the registered address of Acticor Biotech?
      The registered address for Acticor Biotech is WOJO BUILDING 82 AVENUE DU MAINE, PARIS, PARIS, 75014
      What is the Acticor Biotech website address?
      The website address for Acticor Biotech is www.acticor-biotech.com
      Which industry sector does Acticor Biotech operate in?
      Acticor Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SGDDSSpineguard DS
      0.0004 €
      (300.00%)
      		1.34M
      MLCOTCoretech 5
      0.05 €
      (96.08%)
      		2.15k
      BNBSTonner Drones
      0.003 €
      (50.00%)
      		3.21M
      LUDSLucibel DS
      0.0007 €
      (40.00%)
      		400.23k
      ALVIOValerio Therapeutics
      0.083 €
      (39.50%)
      		2.29M
      ALCYBCybergun
      0.0002 €
      (-33.33%)
      		294.97M
      ABLDABL Diagnostics
      5.60 €
      (-22.76%)
      		4.5k
      ALALOAcheterLouerFR
      0.0033 €
      (-21.43%)
      		44.77M
      DMSBSDiagnostic Medical Systems
      0.004 €
      (-20.00%)
      		1.3k
      ALEXPOne Experience
      0.38 €
      (-19.15%)
      		170
      ATOAtos SE
      0.004 €
      (-4.76%)
      		494.38M
      ALCYBCybergun
      0.0002 €
      (-33.33%)
      		294.97M
      BCPBanco Comercial Portugues SA
      0.5516 €
      (4.00%)
      		88.1M
      ALEUPEuroplasma
      0.0202 €
      (1.51%)
      		73.21M
      ALTDTonner Drones
      0.0234 €
      (-14.60%)
      		60.14M

      Discussion

      View Full Feed
      chklingon chklingon 3 minutes ago
      ROFL.... a site dedicated to Tesla hate? Now, let's be fair. You did say "spontaneous combustion." The number of these is tiny. (Even with GM, who made this a thing a few years ago with the Chevy Bolt debacle.) Most of the fires are associated with crashes. Both gas and battery can and do catch fire
      TSLA
      Stillmoremanz Stillmoremanz 4 minutes ago
      How about now 
      CBDW
      fuagf fuagf 4 minutes ago
      I think it's pretty clear Biden would have lost worse than Harris did ..
      https://www.washingtonpost.com/politics/2025/01/08/biden-would-have-beaten-trump/

      I think on the evidence, Philip Bump, is right.
      CommodityCoverage CommodityCoverage 4 minutes ago
      As detailed by Streetwise Reports, a renewed focus on nuclear power as a clean energy source is driving uranium demand with more than 20 countries committed to tripling nuclear power capacity by 2050, however, uranium supply faces constraints due to operational challenges and trade policies: https:/
      SYHBF
      JoJr JoJr 4 minutes ago
      Good move.

      I'd accumulate too at these prices.

      It does look like the company is buying...

      or some whale with lots of cash.
      RDAR
      Cosa Cosa 5 minutes ago
      Lol 😂 👍️
      IOVA
      LJ-Bodhi LJ-Bodhi 5 minutes ago
      They're called makeeasymoneyonchatrooms.com. I get $20/post and then $100/reply to my posts. Please reply, and thank you from the bottom of my bank account.

      Just curious. Do you know this "company" hocked horse supplements as it's main "moneymaker" and fizzled out on fancy water, lon
      BDPT
      Chachang1 Chachang1 5 minutes ago
      Someone thought that this was a good time to get in yesterday.
      CBMJ
      Investor2014 Investor2014 5 minutes ago
      Enough to scramble the mind.
      AVXL
      Monroe1 Monroe1 5 minutes ago
      Dow Jones 41,488.19 +674.62 (+1.65%)
      Nasdaq 17,754.09 +451.07 (+2.61%)
      S&P 500 5,638.94 +117.42 (+2.13%)

      Crude oil 67.14 +0.89%
      Gold 2,990.80 -0.02%
      US 10 year 43.08 +0.80%
      Bitcoin 84,391.48 +3.07%
      Heck of a rally in the stock
      NBRI
      awesomed007 awesomed007 6 minutes ago
      Added today👍💎💥
      RDAR
      Signor Signor 6 minutes ago
      Very plausible RNVA is piloting Curallo. Rolled out internally! Assisted living with 200+ units coming into the picture translates into more clients for curallo, more exposure for curallo and more revenue. Dont forget RNVA also has $17.5m in preferred shares of innovaqor. Seamus building a Juggernau
      RNVA
      Signor Signor 6 minutes ago
      Very plausible RNVA is piloting Curallo. Rolled out internally! Assisted living with 200+ units coming into the picture translates into more clients for curallo, more exposure for curallo and more revenue. Dont forget RNVA also has $17.5m in preferred shares of innovaqor. Seamus building a Juggernau
      RNVA
      XMaster2023 XMaster2023 6 minutes ago
      After DCVax-L & Flaskworks are approved, the demand for off label treatment of other cancers will skyrocket. Those highly trained people will be SWAMPED. Then The manufacturers will need that 200,000 SF facility. Somewhere. That is why NWBO and Advent is separate. CRL will be able to handle Manu
      CRL NWBO
      Chachang1 Chachang1 6 minutes ago
      Yup. Looks like March madness is happening again. What caused the sudden interest?
      RLTR
      RuudSaltis RuudSaltis 6 minutes ago
      I liked the last words that were not bold in your text: …. with select customers. That seems to me very important. Who makes the selection? Or is it limited?
      LWLG
      Vexari Vexari 6 minutes ago
      Ode to be

      www.youtube.com/watch?v=QxIWDmmqZzY A Freebird
      Mr. C Mr. C 7 minutes ago
      AON order possibly?
      TGLO
      luvwetscent luvwetscent 7 minutes ago
      I did...15 years ago
      ELTP
      Chachang1 Chachang1 8 minutes ago
      Great week for sure on this and others in my portfolio. Something is up here for sure. Was hoping for news but now it will probably for sure happen.
      VAPR
      PonderosaPack PonderosaPack 8 minutes ago
      I can taste that 40 burger. 😂 but first - a 30 Burger.
      IONQ
      paulie c paulie c 8 minutes ago
      https://www.sec.gov/ix?doc=/Archives/edgar/data/0000897078/000149315225010288/form8-k.htm

      HOLY SHIT.....The savant that all the cheerleaders were bragging about resigned as CEO and the felon Zimbler is back in charge!!! criminal
      KOAN
      Monroe1 Monroe1 8 minutes ago
      I bought. Glad of it too.
      NBRI
      bcde bcde 8 minutes ago
      My idea:
      End the draconian/stifling bureaucratic control over FnF. Set the right achievable goals for FnF and enable the FnF professionals do their job.
      FNMA

      Your Recent History

      EU
      ALACT
      Acticor Biotech
      CCOM
      PLATINUM
      PLATINUM
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads